Search

Search Results
Results 51 - 60 of 192 for Accident
  • Prexum Combi
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Prexum Combi (perindopril and indapamide) intended for persons living in Australia.
  • Coversyl Plus
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Coversyl Plus (perindopril and indapamide) intended for persons living in Australia.
  • Diamicron 60mg MR
    Drug - 18 Jul 2022
    Consumer Medicine Information (CMI) about Diamicron 60mg MR (containing gliclazide) intended for persons living in Australia.
  • Ardix Gliclazide 60mg MR
    Drug - 18 Jul 2022
    Consumer Medicine Information (CMI) about Ardix Gliclazide 60mg MR (containing gliclazide) intended for persons living in Australia.
  • Prexum
    Drug - 15 Jul 2022
    Consumer Medicine Information (CMI) about Prexum (perindopril) intended for persons living in Australia.
  • Valcyte Powder for Oral Solution
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Valcyte Powder for Oral Solution (valganciclovir) intended for persons living in Australia.
  • Famvir for genital herpes
    Drug - 20 Apr 2020
    Consumer Medicine Information (CMI) about Famvir for genital herpes (famciclovir) intended for persons living in Australia.
  • Norinyl-1
    Drug - 16 Mar 2020
    Consumer Medicine Information (CMI) about Norinyl-1 (Mestranol and Norethisterone) intended for persons living in Australia.
  • Kytril Tablets
    Drug - 19 Oct 2017
    Consumer Medicine Information (CMI) about Kytril Tablets (granisetron hydrochloride) intended for persons living in Australia.
  • Durogesic
    Drug - 13 Apr 2026
    Consumer Medicine Information (CMI) about Durogesic intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback